COLLEONI, MARCO
 Distribuzione geografica
Continente #
EU - Europa 1.871
AS - Asia 1.259
NA - Nord America 1.098
SA - Sud America 104
AF - Africa 23
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.366
Nazione #
US - Stati Uniti d'America 1.044
GB - Regno Unito 676
DE - Germania 494
CN - Cina 413
SG - Singapore 356
IT - Italia 226
VN - Vietnam 136
HK - Hong Kong 123
FR - Francia 90
SE - Svezia 82
BD - Bangladesh 76
BR - Brasile 76
RU - Federazione Russa 72
NL - Olanda 53
IN - India 36
CA - Canada 35
IE - Irlanda 33
ID - Indonesia 27
BE - Belgio 26
FI - Finlandia 24
JP - Giappone 21
ES - Italia 18
TR - Turchia 14
MX - Messico 13
IL - Israele 11
UA - Ucraina 11
AU - Australia 10
PL - Polonia 10
AR - Argentina 9
AT - Austria 9
PT - Portogallo 9
CI - Costa d'Avorio 8
CH - Svizzera 7
DK - Danimarca 7
IQ - Iraq 6
KR - Corea 6
MA - Marocco 6
PE - Perù 6
RO - Romania 6
CO - Colombia 4
EC - Ecuador 4
LB - Libano 4
NO - Norvegia 4
PH - Filippine 4
TH - Thailandia 4
TW - Taiwan 4
CZ - Repubblica Ceca 3
IR - Iran 3
RS - Serbia 3
AZ - Azerbaigian 2
HN - Honduras 2
HU - Ungheria 2
LT - Lituania 2
LU - Lussemburgo 2
MO - Macao, regione amministrativa speciale della Cina 2
PY - Paraguay 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BO - Bolivia 1
CL - Cile 1
DZ - Algeria 1
EG - Egitto 1
ET - Etiopia 1
EU - Europa 1
HR - Croazia 1
IS - Islanda 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
KH - Cambogia 1
KN - Saint Kitts e Nevis 1
MM - Myanmar 1
MY - Malesia 1
NI - Nicaragua 1
QA - Qatar 1
SA - Arabia Saudita 1
SC - Seychelles 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TZ - Tanzania 1
UZ - Uzbekistan 1
VE - Venezuela 1
ZA - Sudafrica 1
ZW - Zimbabwe 1
Totale 4.366
Città #
Southend 630
Frankfurt am Main 435
Singapore 208
Ashburn 129
Hong Kong 92
Dallas 85
San Jose 83
Milan 74
Chandler 73
Beijing 67
Hangzhou 64
Los Angeles 47
Council Bluffs 36
Fairfield 36
Dearborn 35
Hanoi 35
Ho Chi Minh City 34
Santa Clara 34
Dublin 33
Princeton 30
New York 25
Guangzhou 21
Houston 21
Toronto 20
Nanjing 19
Munich 18
Wilmington 16
Boardman 15
Jakarta 15
Lauterbourg 15
Jinan 14
Hefei 13
Bengaluru 12
Brussels 12
Buffalo 12
Cambridge 12
Des Moines 12
Helsinki 12
Rome 12
Ann Arbor 11
Central District 10
Da Nang 10
Moscow 10
Shenyang 10
Turin 10
Turku 10
Columbus 9
Shanghai 9
Woodbridge 9
Abidjan 8
Amsterdam 7
Cangzhou 7
Chicago 7
Haiphong 7
Nuremberg 7
San Diego 7
Seattle 7
São Paulo 7
The Dalles 7
Atlanta 6
Bytom 6
Fuzhou 6
Grafing 6
Redwood City 6
Stockholm 6
Ankara 5
Barcelona 5
Berlin 5
Dong Ket 5
Fremont 5
Haikou 5
Hebei 5
Lisbon 5
Nanchang 5
Naples 5
Newton 5
Tianjin 5
Tokyo 5
Altamura 4
Bexley 4
Brentwood 4
Catania 4
Changsha 4
Falls Church 4
Istanbul 4
Lima 4
London 4
Molenbeek-Saint-Jean 4
Mumbai 4
Ninh Bình 4
Orem 4
Paris 4
Phoenix 4
Taipei 4
Taizhou 4
Belgrade 3
Cagliari 3
Central 3
Charlotte 3
Chennai 3
Totale 2.909
Nome #
Lessons from the Fourth Metronomic and Anti-angiogenic Therapy Meeting, 24-25 June 2014, Milan 761
Genomic and transcriptomic analyses of breast cancer primaries and matched metastases in AURORA, the Breast International Group (BIG) molecular screening initiative 494
Endocrine-responsive lobular carcinoma of the breast: features associated with risk of late distant recurrence 348
Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial 346
Tailoring therapies-improving the management of early breast cancer : St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015 310
Preventing chemotherapy-induced alopecia : a prospective clinical trial on the efficacy and safety of a scalp-cooling system in early breast cancer patients treated with anthracyclines 282
ESR1 gene amplification and MAP3K mutations are selected during adjuvant endocrine therapies in relapsing Hormone Receptor-positive, HER2-negative breast cancer (HR+ HER2- BC) 208
The use of breast imaging for predicting response to neoadjuvant lapatinib, trastuzumab and their combination in HER2-positive breast cancer : results from Neo-ALTTO 198
Preservation of quality of life in patients with human epidermal growth factor receptor 2–positive metastatic breast cancer treated with tucatinib or placebo when added to trastuzumab and capecitabine (HER2CLIMB trial) 198
Pembrolizumab plus trastuzumab in trastuzumab-resistant, advanced, HER2-positive breast cancer (PANACEA): a single-arm, multicentre, phase 1b–2 trial 196
Highlights from the 13th St Gallen International Breast Cancer Conference 2013 : access to innovation for patients with breast cancer: How to speed it up? 191
Low-dose aspirin for the prevention of venous thromboembolism in breast cancer patients treated with infusional chemotherapy after insertion of central vein catheter 158
Metastasis-directed stereotactic radiotherapy and systemic treatment continuation for patients with oligoprogressive metastatic breast cancer 147
Personalizing the treatment of women with early breast cancer : highlights of the st gallen international expert consensus on the primary therapy of early breast Cancer 2013 145
Oral metronomic cyclophosphamide and methotrexate plus fulvestrant in advanced breast cancer patients: A mono-institutional case-cohort report 127
Preoperative and perioperative chemotherapy with 5-fluorouracil as continuous infusion in operable breast cancer expressing a high proliferation fraction : Cytotoxic treatment during the surgical phase 126
Ultra-deep multigene profiling of matched primary and metastatic hormone receptor positive breast cancer patients relapsed after adjuvant endocrine treatment reveals novel aberrations in the estrogen receptor pathway 119
Breast cancer at the end of a successful century: meeting highlights from the First Milan Breast Cancer Conference and discussion paper for the Second Conference (Milan, 14-16 June, 2000) 106
Extendeond Endocrine Therapy and Survival for Breast Cancer Subtypes in Premenopausal Patients 13
null 3
Factor V Leiden mutation in patients with breast cancer and a central venous catheter: Relationship with deep vein thrombosis 1
Extended Endocrine Therapy Following 5 Years of Adjuvant Luteinizing Hormone-Releasing Hormone Agonist in Premenopausal Patients With Node-Positive, Hormone Receptor-Positive Breast Cancer: A Cohort Study 1
Tumor-infiltrating lymphocytes (TILs) are a powerful prognostic marker in patients with triple negative breast cancer treated by induction chemotherapy with or without oral low dose cyclophosphamide-methotrexate maintenance chemotherapy (CMM) 1
Systemic effects of surgery: Quantitative analysis of circulating basic fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF) and transforming growth factor beta (TGF-beta) in breast cancer patients who underwent limited or extendexd surgery 1
Daily low-dose aspirin in cancer patients with central venous catheter: New role for an old drug 1
Response to primary chemotherapy in breast cancer patients with tumors not expressing estrogen and progesteron receptors 1
Circulating endothelial cells (CECs) and progenitors (CEPs) for prediction of response in patients with breast cancer who receive chemotherapy and anti-angiogenic drugs: Different predictive potentials according to drug dose and schedule 1
Correction to: De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 (Annals of Oncology (2017) 28(8) (1700–1712), (S0923753419321817), (10.1093/annonc/mdx308)) 1
Totale 4.484
Categoria #
all - tutte 10.080
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.080


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202129 0 0 0 0 0 0 0 0 0 0 0 29
2021/2022360 30 31 19 17 18 14 18 22 69 39 24 59
2022/2023432 44 35 58 48 30 76 7 26 50 23 29 6
2023/2024418 7 16 8 5 28 20 64 57 28 57 64 64
2024/2025777 65 69 49 85 28 34 22 62 48 65 80 170
2025/20261.435 145 93 141 86 114 73 252 45 118 106 170 92
Totale 4.484